MDRP Spotlight Video: Current Civil and Criminal Enforcement Activities to Improve Corporate Compliance

Last year at the Medicaid Drug Rebate Program 2011, Viveca D. Parker, Assistant United States Attorney, United States Department of Justice, F. Elizabeth Lepic, Assistant Attorney General, MFCU, Office of Attourney General,  Virginia A. Gibson, former Executive Assistant U.S. Attorney for the Eastern District of Pennsylvania Litigation, Arbitration and Employment Practice Group, Hogan Lovells US LLC presented "Current Civil and Criminal Enforcement Activities to Improve Corporate Compliance."

In their discussion, they look at the current state of Medicaid Fraud and current enforcement activities from the Fraud Enforcement Recovery Act and other issues and reasons why the government starts investigations into Pharma companies.



This year at MDRP 2012, Marilyn May, Healthcare Fraud Coordinator, Assistant United States Attorney, United States Department of Justice and returning speaker Virginia "Ginny" Gibson, Partner, Hogan Lovells , LLP will be on hand to present the current state of legal enforcement in 2012, "Current Criminal and Civil Enforcement Activities to Improve Corporate Compliance."  For more information on this presentation and the rest of the program, download the agenda.  If you'd like to join us this September for the event, register today and mention code XP1725BLOG and save 25% off the standard rate!

Preventing business if drug companies executives are convited of fraud

A recent article in the Washington Post states that federal investigators want to prevent drug companies with executives who have been involved in fraud from doing business with the US Government. The new guidelines were posted on October 20 on the office's webpage. This will help keep individuals accountable for their actions.

A few of the new sanctions include:
-Company executives might also be sanctioned if their employers are convicted of misconduct or they may be blocked from doing business with federal agencies.
-Misconduct
-Misdemeanor convictions


What do you think about these new sanctions? Will it allow the government to keep their employees more honest?

Louisiana sues drug companies for fraud

Louisiana believes it paid prices that were up to 6,000% higher than whole sale prices on drugs for their Medicaid program. Between 1991 and 2000, they paid 18 drug makers approximately $850 million. Twenty-seven other states have filed similar charges against the drug companies. Read the full article at Pharmalot.